BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
273 hedge funds and large institutions have $7.92B invested in bluebird bio in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 106 increasing their positions, 81 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $9.81B → $7.92B (-$1.89B)
24% less call options, than puts
Call options by funds: $100M | Put options by funds: $131M
26% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 42
Holders
273
Holding in Top 10
1
Calls
$100M
Puts
$131M
Top Buyers
| 1 | +$141M | |
| 2 | +$121M | |
| 3 | +$53.1M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$48.9M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$26.9M |
Top Sellers
| 1 | -$138M | |
| 2 | -$74.9M | |
| 3 | -$35.4M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$32.9M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$32.5M |